CD22 - CD22 molecule Gene

Species: Macaca mulatta

Gene Type: protein coding
Gene ID: 106994739

CD22 Products (7)

mRNA Protein Name
XM_028838741.1 XP_028694574.1 B-cell receptor CD22 isoform X1
XM_028838742.1 XP_028694575.1 B-cell receptor CD22 isoform X3
XM_028838745.1 XP_028694578.1 B-cell receptor CD22 isoform X3
XM_015123675.2 XP_014979161.2 B-cell receptor CD22 isoform X1
XM_015123676.2 XP_014979162.2 B-cell receptor CD22 isoform X2
XM_028838744.1 XP_028694577.1 B-cell receptor CD22 isoform X3
XM_028838743.1 XP_028694576.1 B-cell receptor CD22 isoform X3
Protein Preferred Names Protein Names

B-cell receptor CD22

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9959 Inotuzumab ozogamicin Inhibitor 99.7% Unkown

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-141602 Pinatuzumab vedotin Inhibitor / Phase 2
Inhibitory Antibodies (6)
Cat. No. Product Name Effect
Purity Phase
HY-P99264 Inotuzumab Inhibitor 97.66% Phase 4
HY-P99289 Epratuzumab 99.53% Phase 3
HY-P99034 Moxetumomab Inhibitor 99.77% Phase 3
HY-P990781 Suciraslimab Inhibitor 97.42% Phase 3
HY-P99230 Pinatuzumab Inhibitor 99.70% Phase 2
HY-P990759 Rezetamig Inhibitor 95.65% Phase 1

Pre-clinical Phase

Bioactive Molecules (6)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990930 Mozistobart 99.21% Unkown
HY-188021 CD22 CAR mRNA / Unkown
HY-185659 6'-BPANeuGc Ligand / Unkown
HY-P9959A Inotuzumab ozogamicin (solution) Inhibitor / Unkown
HY-146081 CD22 ligand-1 Ligand / Unkown
HY-171172 GSC-718 Inhibitor / Unkown
Inhibitory Antibodies (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990283 Anti-Mouse CD22 Antibody (Cy34.1) Inhibitor 99% Unkown
HY-P991550 RFB4 Inhibitor 96.93% Unkown
HY-P99264A Inotuzumab (powder) Inhibitor / Unkown
HY-P991906 TRPH-222 Antibody / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CD22 NCBI NCBI:933